Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Jodie Gregory

Nurse Practitioner Bermuda Run, NC Nurse Practitioner

NPI 1407518475 CMS profile 11277234

152 E Kinderton Way, Bermuda Run, NC 27006

Open in the dashboard

General payments

$3,579

179 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jodie Gregory of Bermuda Run, NC is reported in the CMS Open Payments database as having received $3,579 across 179 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $890 36
2024 General $1,018 50
2023 General $637 52
2022 General $1,034 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jodie Gregory
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Jodie Gregory were reported at $890. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Jodie Gregory Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $1,034 $152 $48–$470 $149
2023 $637 $166 $54–$529 $160
2024 $1,018 $173 $55–$556 $164
2025 $890 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $3,201 173 payments
  2. MML US, Inc. $250 2 payments
  3. Relievant Medsystems, Inc. $69 2 payments
  4. SPR Therapeutics, Inc $34 1 payment
  5. SI-BONE, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $3,579 179 payments
Products named General payments · program years 2022–2025
  1. WaveWriter Alpha Prime 16 $2,037 98 payments
  2. ReActiv8 $250 2 payments
  3. General - Pain Management $242 18 payments
  4. Superion Indirect Decompression System $164 10 payments
  5. General - Therapies $130 4 payments
  6. Intracept Pain $69 2 payments
  7. Intracept Pain $38 1 payment
  8. Intracept Pain $38 1 payment
  9. Intracept Pain $38 1 payment
  10. SPRINT PNS System $34 1 payment
  11. Other $64 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

1,785

Median for Nurse Practitioner: 389

Drug cost

$65,939

Median for Nurse Practitioner: $21,885

Branded share of claims

37.4%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Nucynta Tapentadol Hcl Brand 11 $12,402
Buprenorphine Generic 71 $12,363
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 338 $12,327
Belbuca Buprenorphine Hcl Brand 14 $8,780
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 287 $7,112
Pregabalin Generic 194 $3,547
Gabapentin Generic 205 $2,634
Tizanidine Hcl Generic 105 $1,307
Oxycodone Hcl Generic 63 $975
Tramadol Hcl Generic 147 $876

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$54,047

Medicare's payments for the services billed

Medicare patients

277

Average age 74

Services billed

1,011

158 women, 119 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 34%
Depression 34%
Diabetes 31%
Chronic kidney disease 30%
Osteoporosis 26%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record